Reducing Opioid Mortality in Illinois (ROMI)
降低伊利诺伊州阿片类药物死亡率 (ROMI)
基本信息
- 批准号:10671066
- 负责人:
- 金额:$ 212.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccidentsAcuteAddressAttitudeBuprenorphineCaringCase ManagementChicagoColorCommunitiesCommunity OutreachControl GroupsCriminal JusticeDataDischarge PlanningsDiseaseEffectivenessEffectiveness of InterventionsEnrollmentEnsureEvidence based treatmentFaceFentanylFundingFutureGeographyHarm ReductionHealthHealth systemHeterogeneityHybridsIllinoisIncidenceIndividualInfrastructureInsuranceInterventionJailJusticeLeftMental Health ServicesMethadoneMethodsModelingNaloxoneNarcoticsNational Institute of Drug AbuseOpioidOutcomeOverdosePatientsPersonsPharmaceutical PreparationsPhysiciansPositioning AttributePrisonsProviderPublic HealthRandomized, Controlled TrialsResearch DesignResearch PersonnelResistanceResourcesRiskRuralRural PopulationServicesSiteSocial WorkSocial statusStigmatizationSyringesSystemTestingTherapeuticTravelUniversitiesUrban CommunityUrban PopulationVisitWomanWorkbuprenorphine treatmentcare coordinationcare systemscommunity partnershipcommunity-level factorcultural competencedesigneffectiveness testingeffectiveness/implementation designexperiencefollow-upgeographic barriergun homicideheroin overdosehigh riskimplementation barriersimplementation effortsimplementation evaluationimprovedmedication-assisted treatmentmembermenmortality riskopioid epidemicopioid mortalityopioid overdoseopioid useopioid use disorderopioid useroverdose deathparticipant retentionpeerpeer recoverypragmatic trialprimary outcomerandomized trialrearrestreincarcerationrelapse riskrural arearural patientsrural settingsecondary outcomeservice engagementsubstance usesynthetic opioidtreatment armtreatment groupurban settingwaiver
项目摘要
PROJECT ABSTRACT
More than 2,700 Illinois residents died of opiate overdose in 2017—a number that surpassed the state’s
combined fatalities from road accidents and gun homicide. Individuals leaving jail and prison may be at highest
risk of fatal overdose and other drug-related harms. Severely vulnerable men and women face these risks at
precisely the moment they cross boundaries of fragmented criminal justice, social service, and public health
systems, and are thus most vulnerable to lost follow-up and disengagement from services, or to have other
basic needs left unattended. The challenge may be most acute for detainees who rapidly flow through jail
settings, where unpredictable departures hinder discharge planning and care coordination, and where justice
stakeholders may hold attitudes that stigmatize substance use or resistant to harm reduction interventions.
Individuals returning to Chicago communities of color are near relatively rich resources for both treatment and
harm reduction. Yet they must navigate epicenters of illicit narcotics distribution that feature particularly high
incidence of fatal overdose from heroin, fentanyl, and other synthetic opioids. Rural individuals in Southern
Illinois, may have long travel distances from any methadone facility or any DEA-waivered physician available to
prescribe buprenorphine. Rural patients also face geographic barriers to the provision of naloxone and SSPs.
Many harm reduction services have been designed and implemented to serve urban populations in traditional
centers of opioid use. The acceptability and cultural competence of such rural services remains understudied.
Our proposed multi-site ROMI trial (Reducing Opioid Mortality in Illinois) seeks to address this public health
challenge through improved supports and service linkages to medication-assisted treatment (MAT), naloxone
distribution, and syringe support services (SSPs) provided to justice-involved individuals living with opioid use
disorders. We seek to test whether a unified case management approach that includes peer recovery coaches
can improve treatment engagement and retention in five diverse urban and rural contexts that all experience
high rates of opioid disorders, overdose, and related harms.
We request funds to implement a five-site Randomized Controlled Trial, enrolling at least 1,000 individuals
living with OUD. The ROMI trial will be carried out using a hub-and-spoke model, with centralized long-
standing social services infrastructure at the Community Outreach Intervention Projects (COIP) hosted at the
University of Illinois at Chicago (UIC). COIP provides case management/transition of care services to justice-
involved opioid users, extending resources and technical assistance to less-populated rural areas hardest-hit
by the opioid epidemic. Using a hybrid type-one effectiveness implementation design, we propose a simple but
effective package of treatment and harm reduction interventions to reduce subsequent opioid use and related
harms in diverse contexts. Our pragmatic trial is thus well-positioned to test effectiveness while collecting
contextual data for implementation.
项目摘要
2017年,超过2,700名伊利诺伊州居民死于阿片类药物过量-这一数字超过了该州
交通事故和枪击杀人的死亡人数离开监狱和监狱的个人可能最高
致命过量和其他药物相关危害的风险。极度脆弱的男性和女性面临着这些风险,
恰恰是在他们跨越支离破碎的刑事司法、社会服务和公共卫生的界限时,
因此,最容易失去后续行动和脱离服务,或有其他
基本需求无人照顾。对于那些在监狱中快速流动的被拘留者来说,挑战可能最为严峻
环境,不可预测的离职阻碍出院计划和护理协调,
利益攸关方可能持有鄙视药物使用或抵制减少危害干预措施的态度。
个人返回到芝加哥社区的颜色是附近相对丰富的资源,
减少伤害。然而,他们必须通过非法毒品分销的中心,
海洛因、芬太尼和其他合成阿片类药物过量致死的发生率。南方农村人口
伊利诺伊州,可能有很长的旅行距离,从任何美沙酮设施或任何DEA豁免的医生提供,
开丁丙诺啡农村患者在提供纳洛酮和SSP方面也面临地理障碍。
许多减少危害服务的设计和实施都是为了在传统的
阿片类药物使用中心这种农村服务的可接受性和文化能力仍然没有得到充分研究。
我们提议的多中心ROMI试验(降低伊利诺伊州阿片类药物死亡率)旨在解决这一公共卫生问题
通过改善对药物辅助治疗(MAT)、纳洛酮的支持和服务联系,
分发和注射器支持服务(SSP)提供给与阿片类药物使用有关的个人
紊乱我们试图测试是否有一个统一的案例管理方法,包括同行恢复教练
在五个不同的城市和农村环境中,
阿片类药物紊乱、过量和相关危害的发生率很高。
我们申请资金实施一项五个地点的随机对照试验,至少招募1,000人
与OUD一起生活ROMI试验将采用轴辐式模式进行,集中的长时间,
社区外展干预项目(COIP)的常设社会服务基础设施,
伊利诺伊大学芝加哥分校(UIC)。《刑事组织法组织法》提供案件管理/将护理服务移交司法-
* 使类阿片使用者参与,将资源和技术援助扩大到人口较少的受影响最严重的农村地区
阿片类药物的流行使用混合型1的有效性实施设计,我们提出了一个简单的,但
有效的一揽子治疗和减少危害干预措施,以减少随后的类阿片使用和相关的
在不同背景下的危害。因此,我们务实的审判是很好的定位,以测试有效性,同时收集
用于实施的上下文数据。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ethical Approaches to Vaccine Allocation and Administration in Carceral Settings, With a Focus on Youth.
监狱环境中疫苗分配和管理的道德方法,重点关注青少年。
- DOI:10.1089/jchc.21.05.0041
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Enujioke,SharonC;Knopf,AmeliaS;Aalsma,MatthewC
- 通讯作者:Aalsma,MatthewC
Reducing Opioid Mortality in Illinois (ROMI): A case management/peer recovery coaching critical time intervention clinical trial protocol.
- DOI:10.1016/j.jsat.2021.108348
- 发表时间:2021-09
- 期刊:
- 影响因子:3.9
- 作者:Pho, Mai;Erzouki, Farah;Boodram, Basmattee;Jimenez, Antonio D.;Pineros, Juliet;Shuman, Valery;Claypool, Emily Jane;Bouris, Alida M.;Gastala, Nicole;Reichert, Jessica;Kelly, Marianne;Salisbury-Afshar, Elizabeth;Epperson, Matthew W.;Gibbons, Robert D.;Schneider, John A.;Pollack, Harold A.
- 通讯作者:Pollack, Harold A.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAROLD Alexander POLLACK其他文献
HAROLD Alexander POLLACK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAROLD Alexander POLLACK', 18)}}的其他基金
Alternate Emergency Over Dose Response in Chicago
芝加哥的替代紧急剂量反应
- 批准号:
10618266 - 财政年份:2022
- 资助金额:
$ 212.59万 - 项目类别:
Alternate Emergency Over Dose Response in Chicago
芝加哥的替代紧急剂量反应
- 批准号:
10425012 - 财政年份:2022
- 资助金额:
$ 212.59万 - 项目类别:
Reducing Opioid Mortality in Illinois (ROMI)
降低伊利诺伊州阿片类药物死亡率 (ROMI)
- 批准号:
10402783 - 财政年份:2019
- 资助金额:
$ 212.59万 - 项目类别:
Predictive Analytics Applied to Integrated Administrative Emergency Response Datasets in Chicago - Resubmission 01
预测分析应用于芝加哥综合行政应急响应数据集 - 重新提交 01
- 批准号:
10200643 - 财政年份:2019
- 资助金额:
$ 212.59万 - 项目类别:
Predictive Analytics Applied to Integrated Administrative Emergency Response Datasets in Chicago - Resubmission 01
预测分析应用于芝加哥综合行政应急响应数据集 - 重新提交 01
- 批准号:
9981836 - 财政年份:2019
- 资助金额:
$ 212.59万 - 项目类别:
Reducing Opioid Mortality in Illinois (ROMI)
降低伊利诺伊州阿片类药物死亡率 (ROMI)
- 批准号:
9978033 - 财政年份:2019
- 资助金额:
$ 212.59万 - 项目类别:
Community network driven COVID-19 testing of vulnerable populations in the Central US
社区网络驱动的美国中部弱势群体 COVID-19 测试
- 批准号:
10274013 - 财政年份:2019
- 资助金额:
$ 212.59万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 212.59万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 212.59万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 212.59万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 212.59万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 212.59万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 212.59万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 212.59万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 212.59万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 212.59万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 212.59万 - 项目类别:
Operating Grants